{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:50:10Z","timestamp":1791633010441,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1053\/j.jvca.2026.09.029","type":"journal-article","created":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:28:50Z","timestamp":1789914530000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Angiotensin II in Refractory Shock Secondary to Amlodipine Overdose with Co-Ingestions"],"prefix":"10.1053","author":[{"given":"Abigail J.B.","family":"Poindexter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5793-0781","authenticated-orcid":false,"given":"Jack","family":"Pluenneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Haines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adham","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2026.09.029_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00129784-200707001-00003","article-title":"Calcium channel blockers: differences between subclasses","volume":"7","author":"Frishman","year":"2007","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1053\/j.jvca.2026.09.029_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.01.2012.5643","article-title":"Life-threatening calcium channel blocker overdose and its management","author":"Rizvi","year":"2012","journal-title":"BMJ Case Rep"},{"key":"10.1053\/j.jvca.2026.09.029_bib0003","first-page":"66","article-title":"Calcium channel blocker toxicity causing acute respiratory distress syndrome: A commonly used drug triggering a life-threatening condition","volume":"119","author":"Lodhi","year":"2020","journal-title":"WMJ"},{"key":"10.1053\/j.jvca.2026.09.029_bib0004","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ajem.2004.06.001","article-title":"2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System","volume":"22","author":"Watson","year":"2004","journal-title":"Am J Emerg Med"},{"key":"10.1053\/j.jvca.2026.09.029_bib0005","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3109\/15563650.2011.635149","article-title":"2010 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th annual report","volume":"49","author":"Bronstein","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1053\/j.jvca.2026.09.029_bib0006","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/15563650.2025.2571299","article-title":"2024 annual report of the National Poison Data System\u00a9 (NPDS) from America's Poison Centers: 42th annual report","author":"Beuhler","year":"2025","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1053\/j.jvca.2026.09.029_bib0007","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/CCM.0000000000002087","article-title":"Experts consensus recommendations for the management of calcium channel blocker poisoning in adults","volume":"45","author":"St-Onge","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2026.09.029_bib0008","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1016\/j.afjem.2020.06.014","article-title":"Rapid reversal of vasoplegia with methylene blue in calcium channel blocker poisoning","volume":"10","author":"Saha","year":"2020","journal-title":"Afr J Emerg Med"},{"key":"10.1053\/j.jvca.2026.09.029_bib0009","first-page":"4S","article-title":"Methylene blue leads to rapid correction of vasopressor resistant hypotension in calcium channel blocker overdose","volume":"158","author":"Tillet","year":"2020","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2026.09.029_bib0010","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/01.ccm.0000649204.42605.22","article-title":"Methylene blue for refractory vasoplegia in intentional antihypertensive overdose","volume":"48","author":"Phelps","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2026.09.029_bib0011","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-007402","article-title":"Methylene blue reverses recalcitrant shock in \u03b2-blocker and calcium channel blocker overdose","author":"Aggarwal","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1053\/j.jvca.2026.09.029_bib0012","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2008.01981.x","article-title":"Renin-angiotensin system revisited","volume":"264","author":"Fyhrquist","year":"2008","journal-title":"J Intern Med"},{"key":"10.1053\/j.jvca.2026.09.029_bib0013","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): A pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2026.09.029_bib0014","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2026.09.029_bib0015","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1053\/j.jvca.2019.10.017","article-title":"Adrenergic downregulation in critical care: Molecular mechanisms and therapeutic evidence","volume":"34","author":"Belletti","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.09.029_bib0016","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s13181-022-00885-4","article-title":"The role of angiotensin II in poisoning-induced shock\u2014A review","volume":"18","author":"Chen","year":"2022","journal-title":"J Med Toxicol"},{"key":"10.1053\/j.jvca.2026.09.029_bib0017","first-page":"A12146","article-title":"Refractory hypotension from toxic ingestion of ACE-inhibitor and dihydropyridine calcium-channel blocker treated with angiotensin II","volume":"164","author":"Gries","year":"2024","journal-title":"Critical Care"},{"issue":"4","key":"10.1053\/j.jvca.2026.09.029_bib0018","first-page":"A2010","article-title":"Angiotensin II: A salvage therapy in catecholamine-resistant vasodilatory shock due to calcium channel blockers and ACE inhibitors overdose","volume":"166","author":"Younas","year":"2024","journal-title":"Critical Care"},{"key":"10.1053\/j.jvca.2026.09.029_bib0019","first-page":"A5207","article-title":"Angiotensin II for treatment of calcium channel blocker overdose","volume":"207","author":"Felzer","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.jvca.2026.09.029_bib0020","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s13181-025-01080-x","article-title":"A case of Angiotensin II utilization for refractory shock in a polysubstance overdose","volume":"21","author":"Gilbert","year":"2025","journal-title":"J Med Tox"},{"key":"10.1053\/j.jvca.2026.09.029_bib0021","first-page":"1","article-title":"Hydroxocobalamin as rescue therapy in a patient with refractory amlodipine-induced vasoplegia","volume":"15","author":"Ayasa","year":"2023","journal-title":"Cureus"},{"key":"10.1053\/j.jvca.2026.09.029_bib0022","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13054-023-04446-1","article-title":"Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: An exploratory post-hoc analysis of the ATHOS-3 clinical trial","volume":"27","author":"Wieruszewski","year":"2023","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2026.09.029_bib0023","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","article-title":"Angiotensin II infusion for shock. A multicenter study of postmarketing use","volume":"159","author":"Wieruszewski","year":"2020","journal-title":"CHEST"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077026009389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077026009389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:33:16Z","timestamp":1791631996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077026009389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":23,"alternative-id":["S1053077026009389"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2026.09.029","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin II in Refractory Shock Secondary to Amlodipine Overdose with Co-Ingestions","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2026.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}